Press Releases

Date Title  
Toggle Summary West Announces Participation in Upcoming Investor Conference
EXTON, Pa. , Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in
West Announces Participation in Upcoming Investor Conference
EXTON, Pa. , Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in
Toggle Summary West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack™ System
Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ --  (Booths #F62 & #F10 -Hall 11.1 )   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the
West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack™ System
Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ --  (Booths #F62 & #F10 -Hall 11.1 )   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the
Toggle Summary West Launches Two New Elastomer Product Innovations at CPhI Worldwide
Advanced Elastomer Formulation and AccelTRA® Line Extension Components Expand Company's Drug Containment and Delivery Portfolio; West Marks First Anniversary of Integrated Solutions Program EXTON, Pa. , Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)— West Pharmaceutical Services, Inc.
West Launches Two New Elastomer Product Innovations at CPhI Worldwide
Advanced Elastomer Formulation and AccelTRA® Line Extension Components Expand Company's Drug Containment and Delivery Portfolio; West Marks First Anniversary of Integrated Solutions Program EXTON, Pa. , Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)— West Pharmaceutical Services, Inc.
Toggle Summary West Announces Third-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.
West Announces Third-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices
Scientific Presentations & Trainings Highlight Scientific Leadership in Drug Containment & Delivery EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ --  (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today
West Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices
Scientific Presentations & Trainings Highlight Scientific Leadership in Drug Containment & Delivery EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ --  (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today
Toggle Summary West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery
EXTON, Pa. , Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.
West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery
EXTON, Pa. , Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.
Toggle Summary West to Host Third-Quarter 2019 Conference Call
  EXTON, Pa. , Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, October 24, 2019 ,
West to Host Third-Quarter 2019 Conference Call
  EXTON, Pa. , Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, October 24, 2019 ,
Toggle Summary West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in September.
West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in September.
Toggle Summary West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance.
West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West to Host Second-Quarter 2019 Conference Call
EXTON, Pa., July 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019  financial results before the market opens on Thursday, July 25, 2019 ,
West to Host Second-Quarter 2019 Conference Call
EXTON, Pa., July 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019  financial results before the market opens on Thursday, July 25, 2019 ,
Toggle Summary West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards
Company Announces New AccelTRA® Component Program Product Extension, Showcases Industry Thought Leadership at Conference EXTON, Pa. , May 22, 2019 /PRNewswire/ --  West Pharmaceutical Services , Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards
Company Announces New AccelTRA® Component Program Product Extension, Showcases Industry Thought Leadership at Conference EXTON, Pa. , May 22, 2019 /PRNewswire/ --  West Pharmaceutical Services , Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is
Toggle Summary West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.
West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.
Toggle Summary West Announces First-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.
West Announces First-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.
West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.
Toggle Summary West to Host First-Quarter 2019 Conference Call
EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,
West to Host First-Quarter 2019 Conference Call
EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,
Toggle Summary West Expands Presence in Korea with New Sales Office
SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West
West Expands Presence in Korea with New Sales Office
SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West
Toggle Summary West Opens New Digital Technology Center in Bengaluru, India
BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and
West Opens New Digital Technology Center in Bengaluru, India
BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and
Toggle Summary West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019
West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019
Toggle Summary West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary
West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary
Toggle Summary West to Host Fourth-Quarter and Full-Year 2018 Conference Call
EXTON, Pa. , Jan. 31, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday,
West to Host Fourth-Quarter and Full-Year 2018 Conference Call
EXTON, Pa. , Jan. 31, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday,
Toggle Summary West Announces Quarterly Dividend and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019 , to shareholders of record as of January
West Announces Quarterly Dividend and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019 , to shareholders of record as of January
Toggle Summary West Announces Participation in Upcoming November Investor Conferences
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in November.
West Announces Participation in Upcoming November Investor Conferences
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in November.
Toggle Summary West Announces Third-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and adjusted-diluted EPS guidance for full-year 2018.  Executive
West Announces Third-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and adjusted-diluted EPS guidance for full-year 2018.  Executive
Toggle Summary West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award.
West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award.
Toggle Summary West to Host Third-Quarter 2018 Conference Call
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018 ,
West to Host Third-Quarter 2018 Conference Call
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018 ,
Toggle Summary West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
West named as finalist in CPhI Pharma Awards EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce a new Integrated Solutions Program to help to
West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
West named as finalist in CPhI Pharma Awards EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce a new Integrated Solutions Program to help to
Toggle Summary West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award
EXTON, Pa. , Sept. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green , has received the CEO Connection's 2018 Social Impact Award.
West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award
EXTON, Pa. , Sept. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green , has received the CEO Connection's 2018 Social Impact Award.
Toggle Summary West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at three investor conferences in
West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at three investor conferences in
Toggle Summary West Announces Second-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary Second-quarter
West Announces Second-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary Second-quarter
Toggle Summary West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
EXTON, Pa. , July 19, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced
West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
EXTON, Pa. , July 19, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced
Toggle Summary West to Host Second-Quarter 2018 Conference Call
EXTON, Pa. , July 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2018 financial results before the market opens on Thursday, July 26, 2018 ,
West to Host Second-Quarter 2018 Conference Call
EXTON, Pa. , July 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2018 financial results before the market opens on Thursday, July 26, 2018 ,
Toggle Summary West Appoints Bernard Birkett to Chief Financial Officer
EXTON, Pa. , June 21, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer,
West Appoints Bernard Birkett to Chief Financial Officer
EXTON, Pa. , June 21, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer,
Toggle Summary West's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award
EXTON, Pa. , June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination
West's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award
EXTON, Pa. , June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination
Toggle Summary West Announces Participation in Upcoming June Investor Conferences
EXTON, Pa. , May 24, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in June.
West Announces Participation in Upcoming June Investor Conferences
EXTON, Pa. , May 24, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in June.
Toggle Summary West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 3, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018 , to shareholders of record as of July 18, 2018
West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 3, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018 , to shareholders of record as of July 18, 2018
Toggle Summary West Announces First-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary First-quarter 2018
West Announces First-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary First-quarter 2018
Toggle Summary West to Host First-Quarter 2018 Conference Call
EXTON, Pa. , April 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018 ,
West to Host First-Quarter 2018 Conference Call
EXTON, Pa. , April 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018 ,
Toggle Summary West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
Toggle Summary West Chief Financial Officer William Federici Announces Plans to Retire
EXTON, Pa. , March 2, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William Federici , Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to
West Chief Financial Officer William Federici Announces Plans to Retire
EXTON, Pa. , March 2, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William Federici , Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to
Toggle Summary West Appoints Silji Abraham Chief Digital and Transformation Officer
EXTON, Pa. , Feb. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Officer, and will be
West Appoints Silji Abraham Chief Digital and Transformation Officer
EXTON, Pa. , Feb. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Officer, and will be